COVID-19 and diabetes management: What should be considered?

被引：83
|
作者：
Ceriello, Antonio [1 ]
Stoian, Anca Pantea [2 ]
Rizzo, Manfredi [3 ,4 ]
机构：
[1] IRCCS MultiMed, Via Gaudenzio Fantoli 16-15, I-20138 Milan, Italy
[2] Carol Davila Univ Med, Diabet Nutr & Metab Dis Dept, Bucharest, Romania
[3] Univ South Carolina, Div Endocrinol Diabet & Metab, Dept Med, Columbia, SC 29208 USA
[4] Univ Palermo, Dept Hlth Promot Mother & Child Care, Internal Med & Med Specialties, Palermo, Italy
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2020年 / 163卷
关键词：
Cardiovascular disease; COVID-19; Diabetes; DPP4; GLP-1RA; Pioglitazone; Hydroxychloroquine; SGLT-2; INCRETIN-BASED THERAPIES;
D O I：
10.1016/j.diabres.2020.108151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Should statins be considered for the management of mucormycosis in COVID-19?
    Chatterjee, Subhankar
    Vardhan, Bhagya
    Singh, Deepa Kumari
    Maitra, Abhishek
    Ojha, Umesh Kumar
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (04)
  • [2] COVID-19 and Diabetes: What Should We Expect?
    Pedrosa, Marlus da Silva
    Neves Nogueira, Fernando
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2020, 14 (06): : 1133 - 1134
  • [3] Diabetes and the COVID-19 Pandemic: What Should the Diabetes Patients Know?
    Shahwan, Moyad
    Hassan, Nageeb
    Alkhoujah, Sahab
    Jairoun, Ammar
    Zyoud, Samer
    Varma, Sudhir
    PHARMACEUTICAL SCIENCES, 2020, 26 : S87 - S90
  • [4] Should ethanol be considered a treatment for COVID-19?
    Manning, Thomas J.
    Thomas-Richardson, Jenu
    Cowan, Matthew
    Thomas-Richardson, Govind
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (09): : 1169 - 1171
  • [5] SHOULD STATINS BE CONSIDERED FOR TREATMENT OF COVID-19 PATIENTS?
    Javed, Muhammad Ali
    Alsaei, Ahmed
    Onyambu, Steve
    Mateen, Pamir
    Khan, Azam
    Sadaka, Farid
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 88 - 88
  • [6] Con: Venoarterial ECMO Should Not Be Considered in Patients With COVID-19
    McLean, Duncan J.
    Henry, Mark
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2021, 35 (03) : 707 - 710
  • [7] COVID-19 vaccines and filler reactions: Should it be considered as a concern?
    Aryanian, Zeinab
    Balighi, Kamran
    Emadi, Seyed Naser
    Razavi, Zahra
    Hatami, Parvaneh
    Afshar, Zeinab Mohseni
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (12) : 6564 - 6567
  • [8] Should COVID-19 be considered cardiovascular disease risk equivalent?
    Kow, Chia Siang
    Ramachandram, Dinesh Sangarran
    Hasan, Syed Shahzad
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 377 : 123 - 123
  • [9] Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?
    Toshiaki Iba
    Jean Marie Connors
    Alex C. Spyropoulos
    Hideo Wada
    Jerrold H. Levy
    International Journal of Hematology, 2021, 113 : 330 - 336
  • [10] Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?
    Iba, Toshiaki
    Connors, Jean Marie
    Spyropoulos, Alex C.
    Wada, Hideo
    Levy, Jerrold H.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (03) : 330 - 336
12345